House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Cardiology

Hypertension in adults: diagnosis and management

NICE · 2026 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE guideline NG136 covers adults with hypertension, including those with type 2 diabetes. It addresses blood pressure measurement technique, postural hypotension, and diagnosis using clinic readings confirmed by ambulatory (ABPM) or home (HBPM) monitoring. It also covers cardiovascular risk and target organ damage assessment, lifestyle measures, thresholds for starting drugs, and clinic and out-of-office targets. Drug treatment is set out as a stepwise pathway from step 1 to resistant hypertension, and the guideline defines criteria for same-day specialist referral. For chronic kidney disease, type 1 diabetes and pregnancy, it links to other NICE guidelines where management differs.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Measuring blood pressure and postural hypotension

  • Staff who measure blood pressure need adequate initial training and periodic performance review. Devices must be validated, maintained and recalibrated. Standardise a relaxed, temperate setting with the person quiet and seated, the arm supported, and a correctly sized cuff. Palpate the radial or brachial pulse first, because automated devices may be inaccurate with an irregular pulse (for example, atrial fibrillation). If the pulse is irregular, measure manually by brachial auscultation. [1]
  • In people with postural symptoms such as falls or dizziness, measure blood pressure lying down (or seated if lying is inconvenient), then measure again after standing for at least 1 minute. If systolic pressure falls by 20 mmHg or more, or diastolic by 10 mmHg or more: - consider causes, including current medication; - use standing readings from then on; - consider specialist referral if symptoms persist despite addressing likely causes. [1]
  • If the person is symptomatic but the drop is below threshold after a seated baseline, repeat the measurements starting supine. Consider specialist assessment if readings do not confirm postural hypotension despite suggestive symptoms. [1]

Diagnosing hypertension

  • When considering hypertension, measure blood pressure in both arms. If the difference exceeds 15 mmHg, repeat; if it persists, use the arm with the higher reading thereafter. If clinic blood pressure is 140/90 mmHg or higher, take a second reading, and a third if the second differs substantially. Record the lower of the last 2 readings. [1]
  • For clinic blood pressure between 140/90 and 180/120 mmHg, offer ABPM to confirm the diagnosis. Offer HBPM if ABPM is unsuitable or not tolerated. Hypertension is confirmed when clinic blood pressure is 140/90 mmHg or higher and the ABPM daytime or HBPM average is 135/85 mmHg or higher. [1]
  • ABPM: take at least 2 readings per hour during usual waking hours and use the average of at least 14 waking readings. HBPM: take 2 consecutive seated readings at least 1 minute apart, twice daily (ideally morning and evening), for at least 4 days and ideally 7. Discard the first day's readings and average the rest. [1]
  • Staging definitions: - Stage 1: clinic 140/90 to 159/99 mmHg, with an out-of-office average of 135/85 to 149/94 mmHg. - Stage 2: clinic 160/100 mmHg or higher but below 180/120 mmHg, with an out-of-office average of 150/95 mmHg or higher. - Stage 3 (severe): clinic systolic 180 mmHg or higher, or diastolic 120 mmHg or higher. [1]
  • While awaiting confirmation, investigate for target organ damage, then formally assess cardiovascular risk with a risk tool. Use clinic readings to calculate cardiovascular risk. [1]
  • Offer everyone with hypertension: - urine albumin:creatinine ratio and reagent-strip haematuria testing; - blood tests for HbA1c, electrolytes, creatinine, eGFR, and total and HDL cholesterol; - fundoscopy for hypertensive retinopathy; - a 12‐lead ECG. [1]
  • If hypertension is not diagnosed: - recheck clinic blood pressure at least every 5 years; - consider more frequent checks if it is below 140/90 mmHg but still raised; - offer healthy-living advice to people with raised readings. If target organ damage is present, consider investigating alternative causes. [1]

Lifestyle interventions

  • Offer lifestyle advice to people with suspected or diagnosed hypertension and repeat it periodically. Ask about diet and exercise, and encourage reduced alcohol intake in those who drink excessively. Discourage excessive caffeine and offer help to stop smoking. [1]
  • Encourage low dietary sodium by reducing or substituting salt. Potassium chloride substitutes should not be used by older people, people with diabetes, pregnant women, people with kidney disease, or those taking some antihypertensives such as ACE inhibitors or ARBs. Do not offer calcium, magnesium or potassium supplements to lower blood pressure. [1]

Starting antihypertensive drug treatment

  • Offer drug treatment plus lifestyle advice to adults of any age with persistent stage 2 hypertension. Use clinical judgement in frailty or multimorbidity. [1]
  • For adults under 80 with persistent stage 1 hypertension, discuss drug treatment plus lifestyle advice when 1 or more of these apply: target organ damage, established cardiovascular disease, renal disease, diabetes, or an estimated 10‐year cardiovascular risk of 10% or more. Use clinical judgement in frailty or multimorbidity. Before starting, discuss individual risk, treatment preferences (including no treatment), and risks and benefits. [1]
  • Consider drug treatment plus lifestyle advice in two further groups: - adults under 60 with stage 1 hypertension and a 10‐year risk below 10%, noting that 10‐year risk may underestimate lifetime risk; - people over 80 with stage 1 hypertension and clinic blood pressure over 150/90 mmHg, using clinical judgement in frailty or multimorbidity. For adults under 40, consider specialist evaluation for secondary causes and of long-term benefit and risk. In anyone with features suggesting a secondary cause, consider specialist investigations. [1]

Monitoring and blood pressure targets

  • Monitor treatment response with clinic readings. Reduce clinic blood pressure to below 140/90 mmHg in adults under 80 and maintain it there. In adults aged 80 and over, reduce it to below 150/90 mmHg and maintain it there, using clinical judgement in frailty or multimorbidity. Targets are the same with or without cardiovascular disease. [1]
  • When using ABPM or HBPM to monitor treatment, use waking-hours averages. Aim for below 135/85 mmHg under 80 and below 145/85 mmHg at 80 and over, using clinical judgement in frailty or multimorbidity. Consider adding ABPM or HBPM to clinic readings when a white-coat effect or masked hypertension is identified. Out-of-office equivalents are 5 mmHg lower than clinic values. [1]
  • Check for postural hypotension in people with hypertension who have type 2 diabetes, postural symptoms, or are aged 80 and over. With a significant drop or symptoms, treat to a standing blood pressure target. [1]
  • Advise people who self-monitor to use HBPM. For those using HBPM, provide training and advice on home monitors and tell them what to do if they are off target. Provide an annual review covering blood pressure, support, lifestyle, symptoms and medication. [1]

Choosing and stepping up drug treatment

  • At step 1, offer an ACE inhibitor or ARB to adults with type 2 diabetes (any age or family origin), and to adults under 55 not of Black African or African–Caribbean origin. For Black African or African–Caribbean adults, consider an ARB in preference to an ACE inhibitor. Switch to an ARB if an ACE inhibitor is not tolerated (for example, cough). Do not combine an ACE inhibitor with an ARB. These drugs should not be used in pregnancy, breastfeeding or planned pregnancy unless absolutely necessary, with risks and benefits discussed. [1]
  • At step 1, offer a CCB to adults aged 55 or over without type 2 diabetes, and to Black African or African–Caribbean adults of any age without type 2 diabetes. Offer a thiazide-like diuretic if a CCB is not tolerated (for example, oedema) or if there is evidence of heart failure. When starting or changing a diuretic, prefer a thiazide-like agent such as indapamide over bendroflumethiazide or hydrochlorothiazide. Continue those older agents if blood pressure is stable and well controlled. [1]
  • Before stepping up, discuss whether medicines are taken as prescribed. If blood pressure is uncontrolled on step 1 ACE inhibitor or ARB, offer a choice of 1 added drug: a CCB or a thiazide-like diuretic. [1]
  • If blood pressure is uncontrolled on step 1 CCB, offer a choice of 1 added drug: an ACE inhibitor, an ARB or a thiazide-like diuretic. In people of Black African or African–Caribbean origin without type 2 diabetes who are uncontrolled on step 1, consider an ARB rather than an ACE inhibitor as the added drug. [1]
  • Before escalating further, confirm optimal tolerated doses and discuss adherence. If blood pressure is uncontrolled on step 2, offer an ACE inhibitor or ARB plus a CCB plus a thiazide-like diuretic. Failure of this triple therapy at optimal tolerated doses defines resistant hypertension. [1]
  • In resistant hypertension, before further treatment, confirm raised clinic readings with ambulatory or home recordings, assess for postural hypotension and discuss adherence. Then consider a fourth drug (step 4) or seek specialist advice. [1]
  • At step 4: - If potassium is 4.5 mmol/l or less, consider low-dose spironolactone, with particular caution if eGFR is reduced because of hyperkalaemia risk. With this further diuretic therapy, check sodium, potassium and renal function within 1 month, then as needed. - If potassium is above 4.5 mmol/l, consider an alpha-blocker or beta-blocker. Seek specialist advice if blood pressure remains uncontrolled on optimal tolerated doses of 4 drugs. [1]

Severe hypertension and same-day referral

  • For clinic blood pressure of 180/120 mmHg or higher without features requiring same-day referral, investigate for target organ damage as soon as possible. - If damage is found, consider starting drugs immediately without awaiting ABPM or HBPM. - If not, confirm by repeating clinic blood pressure within 7 days, or consider ABPM (HBPM if unsuitable) with clinical review within 7 days. [1]
  • Refer for same-day specialist assessment if clinic blood pressure is 180/120 mmHg or higher with either of the following: - retinal haemorrhage or papilloedema (accelerated hypertension); - life-threatening symptoms such as new confusion, chest pain, signs of heart failure or acute kidney injury. Also refer the same day for suspected phaeochromocytoma, for example labile or postural hypotension, headache, palpitations, pallor, abdominal pain or diaphoresis. [1]

Limitations and use

  • Covers adults only. For chronic kidney disease, type 1 diabetes and pregnancy or breastfeeding, the guideline defers to separate NICE guidelines where management differs; those recommendations are not reproduced here.
  • The guideline's clinic target tables for people with type 1 diabetes or chronic kidney disease (which vary by age and albumin:creatinine ratio) are not summarised here; consult tables 1 and 2 and the linked guidelines.
  • For people with cardiovascular disease, disease-specific drug indications follow other NICE condition guidelines; this guideline's drug pathway applies if blood pressure remains uncontrolled.
  • Research recommendations, rationale and impact sections, and evidence reviews were not part of the reviewed source. Flowcharts and visual algorithms were available only as alternative text.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Hypertension in adults: diagnosis and management

    Guideline recommendation text consulted

Original guideline

Publication details

Issuing organisation
NICE
First published
28 August 2019
Publisher’s latest update
26 February 2026
Resource type
Clinical guideline · House clinical summary

Earlier House summaries: hypertension in adults nice

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Measuring blood pressure and postural hypotension
  • Diagnosing hypertension
  • Lifestyle interventions
  • Starting antihypertensive drug treatment
  • Monitoring and blood pressure targets
  • Choosing and stepping up drug treatment
  • Severe hypertension and same-day referral
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House